Camellia Sinensis Leaf Extract, the botanical source of green tea, has transcended its traditional role as a simple beverage ingredient to become a cornerstone of the global functional food, pharmaceutical, and cosmeceutical industries. At Jiangxi Serum Pharma Industries Co., Ltd., we recognize that the "Best Supplier" isn't defined just by volume, but by the ability to deliver precise molecular profiles tailored to specific biological outcomes.
Our research indicates that the therapeutic efficacy of green tea extract is heavily dependent on the synergistic ratio of its secondary metabolites: Epigallocatechin Gallate (EGCG), Epicatechin (EC), Epigallocatechin (EGC), and the unique amino acid L-theanine. As a leading Chinese supplier, we leverage Jiangxi’s unique high-altitude tea plantations and state-of-the-art CO2 supercritical extraction technology to provide extracts with up to 98% purity, meeting USP/BP pharmaceutical standards.
The global green tea extract market is projected to reach a valuation of USD 4.5 billion by 2028, driven by the "Clean Label" movement and the rising demand for natural antioxidants. Industrially, there is a massive shift from crude powders to standardized extracts. Large-scale manufacturers in Europe and North America are increasingly sourcing from China due to the maturity of the supply chain and the rapid adoption of international quality standards.
Dominating the weight management and metabolic health sectors, where EGCG acts as a natural thermogenic agent.
Green tea polyphenols are utilized for their UV-protective and anti-inflammatory properties in high-end skincare.
Purified catechins are currently being researched for their neuroprotective roles in degenerative disease therapy.
The future of Camellia Sinensis extracts lies in Bioavailability Enhancement. Crude extracts often suffer from poor intestinal absorption. Serum Pharma’s technical roadmap includes:
| Specification Type | Standard Content | Primary Application |
|---|---|---|
| Polyphenols 50%-98% | UV/HPLC Tested | General Supplements & Food |
| EGCG 40%-95% | High Purity Pk | Metabolic Health & Clinical Trials |
| Water Soluble / Instant | Low Caffeine | Ready-to-Drink (RTD) Beverages |
Why source from Jiangxi, China? Jiangxi Serum Pharma operates at the heart of China’s premier tea-growing region. Our supply chain resilience is built on three pillars:
In the European market, our extract is favored for its organic-compliant processing. In the Southeast Asian market, our high-solubility instant tea powders dominate the functional beverage sector. For North American clients, we focus on high-purity capsules that meet rigorous third-party testing requirements.
Established in 2017, we have nearly 10 years of experience exporting biological products, vaccines, and western medicines. Our annual sales exceed 10 million USD, backed by 200 close-related suppliers.
Our nutritional ingredients cover plant extracts, plant oils, proteins, and probiotics. We maintain body health and balance with purity derived from nature.
We cooperate on Pre-Mix, Co-Crystallization, and Bio-Fermentation services to monitor cutting-edge market developments.
Exploring the shift toward sustainable squalene sources in the cosmetic industry.
Why Dexamethasone Sodium Phosphate API remains a critical molecule globally.
Oral small-molecule GLP1 weight-loss drug approved, revolutionizing the metabolic treatment landscape.
A: We primarily use water extraction and ethanol extraction for general supplements, and Supercritical CO2 Extraction for high-purity EGCG (>95%) to ensure no solvent residues.
A: Every batch undergoes ICP-MS testing to ensure Lead, Arsenic, Cadmium, and Mercury levels comply with EU and FDA stringent regulations.
A: Yes, we provide customization services for specific EGCG:L-Theanine ratios, catering to both cognitive health and weight loss formulations.
A: For standardized extracts, our lead time is typically 7-10 working days, thanks to our robust inventory management in Jiangxi.
